Articles by Francesca Scassellati Sforzolini

China’s Biotech Boom
China’s transition from a manufacturer of generic drugs to a powerhouse of biotech innovation is redrawing the pharmaceutical landscape. Europe in particular needs to sit up and take notice.
5 min read
All Eyes on Biotech
As we enter this new biotechnology revolution, Europe eyes competition with US dominance. By Brunswick’s Francesca Scassellati Sforzolini and Kelan Murphy.
7 min read
An AI Conversation Unlike Any Other
How the EU regulates AI in healthcare could have implications far beyond the continent. Brunswick’s Francesca Scassellati Sforzolini reports.
12 min read
The EU’s Chance to Tackle Superbugs and Shortages
As the European Commission gets set to review the EU’s pharmaceutical legislation, two issues demand particular attention: ensuring supplies of key medicines, especially antibiotics—and encouraging the innovation needed to maintain the therapeutic options available, which…
9 min read
Issue 22: Acceleration
A Vaccine Expert on Miracles, Misinformation and Missing Data
The Executive Director of Vaccines Europe sees cause for celebration—and concern.
11 min read